ArticleACS omega2025

Study on the Construction and Anti-Tumor Effect of aPDL1/aMUC1 Double Antibody Modification of Doxorubicin Liposome.

Shouzhen Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.